Foreword

Diabetic kidney disease is by far the most common cause of kidney failure requiring renal replacement therapy in the Western world. It is also rapidly becoming the number one cause of kidney failure in many developing nations. There have been many innovations over the past three decades involving both blood pressure and glucose control. These have translated into markedly slowing progression of kidney disease from a loss of 10-12 ml/min/year to 2-3 ml/min/year, thus, delaying the time to dialysis. Additionally, new classes of medication for managing glycemic control have resulted in marked cardiovascular event reduction as well as further slowing of kidney disease associated with diabetes.

This book summarizes the latest literature over the spectrum of diabetic kidney disease and provides practical applications of this knowledge for the student, resident and practitioner. It serves as a good resource for anyone interested in gaining insight from the results of trials and their application to patient management. It is highly recommended for all.